Not long ago, Jatana et al. presented a purely negative depletion process using erythrocyte lysis followed by immunomagnetic labeling with CD45-antibodies and immunocytochemical staining against CD45, CK and DAPI to separate and quantify CTC in HNSCC [9]. This evidence concerns the gene PTPRC and head and neck squamous cell carcinoma.